ArticleFrontiers in pharmacology2021

Rivaroxaban Modulates TLR4/Myd88/NF-Kβ Signaling Pathway in a Dose-Dependent Manner With Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression.

Walaa Yehia Abdelzaher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.